Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020

Johannes Hayer, Dusanka Kasapic, Claudia Zemmrich
doi: https://doi.org/10.1101/2020.12.22.20248614

Article usage

Article usage: December 2020 to July 2025

AbstractFullPdf
Dec 202056714131
Jan 202186854340
Feb 202128963107
Mar 20213155277
Apr 20211874749
May 20212101567
Jun 20211351034
Jul 2021106858
Aug 2021721229
Sep 2021111939
Oct 2021106725
Nov 2021101620
Dec 2021821316
Jan 2022741918
Feb 2022651018
Mar 202263516
Apr 20227117
May 202259111
Jun 20224723
Jul 20221616
Aug 20222446
Sep 202230011
Oct 20223509
Nov 20221625
Dec 20221436
Jan 202331210
Feb 20231634
Mar 20231720
Apr 20232038
May 20231149
Jun 20231959
Jul 2023904
Aug 2023191310
Sep 20231253
Oct 20231804
Nov 202324115
Dec 20231013
Jan 2024912
Feb 20241705
Mar 2024655
Apr 20241257
May 2024411
Jun 20241025
Jul 20241447
Aug 2024945
Sep 202421311
Oct 2024963
Nov 20241758
Dec 20242076
Jan 20252956
Feb 20252985
Mar 2025592112
Apr 20255059
May 20254295
Jun 202550109
Jul 2025410
Back to top
Posted December 24, 2020.
Download PDF
Data/Code
Email
Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020
Johannes Hayer, Dusanka Kasapic, Claudia Zemmrich
medRxiv 2020.12.22.20248614; doi: https://doi.org/10.1101/2020.12.22.20248614
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area